Skip to main content
Log in

Preliminary results of preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for clinically resectable T3 rectal cancer

  • Original Contributions
  • Published:
Diseases of the Colon & Rectum

Abstract

PURPOSE: We report the downstaging, sphincter preservation, acute toxicity, and preliminary local control and survival results of preoperative 5-fiuorouracil (5-FU), low-dose leucovorin (LV), and concurrent radiation therapy followed by postoperative LV/5-FU for treatment of patients with clinically resectable T3 rectal cancer. MATERIALS AND METHODS: A total of 32 patients received two monthly cycles of preoperative LV/5-FU (bolus daily×5). Radiation therapy (5,040 cGy) began concurrently on day 1. Postoperatively, patients received a median of two monthly cycles of LV/5-FU (range, 0–10). RESULTS: The complete response rate was 9 percent pathologic and 13 percent clinical, for a total of 22 percent. Total Grade 3+ acute toxicity during the preoperative combined modality segment was 25 percent (8/32). Of the 20 patients who were thought to initially require an abdominoperineal resection and for whom the intent of treatment was sphincter preservation, 17 (85 percent) were able to undergo sphincter-preserving surgery. With a median follow-up of 22 (3–59) months, none have developed local failure, and the three-year actuarial diseasefree survival rate was 60 percent. CONCLUSION: Our data reveal encouraging downstaging, sphincter preservation, and acute toxicity with this regimen. Additional follow-up is needed to assess the long-term local control and survival rates.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. National Institutes of Health Consensus Conference. Adjuvant therapy for patients with colon and rectal cancer. J Am Med Assoc 1990;264:1444–50.

    Google Scholar 

  2. Minsky BD, Kemeny N, Cohen AM,et al. Preoperative high-dose leucovorin/5-fluorouracil and radiation therapy for unresectable rectal cancer. Cancer 1991;67:2859–66.

    PubMed  Google Scholar 

  3. Minsky BD, Cohen AM, Kemeny N,et al. Efficacy of pre-operative 5-FU, high dose leucovorin, and sequential radiation therapy for unresectable rectal cancer. Cancer 1993;71:3486–92.

    PubMed  Google Scholar 

  4. Minsky BD, Cohen AM, Kemeny N,et al. Pre-operative combined 5-FU, low dose leucovorin, and sequential radiation therapy for unresectable rectal cancer. Int J Radiat Oncol Biol Phys 1993;25:821–7.

    PubMed  Google Scholar 

  5. Minsky BD, Cohen AM, Enker WE,et al. Pre-operative 5-FU, low dose leucovorin, and concurrent radiation therapy for rectal cancer. Cancer 1993;73:273–8.

    Google Scholar 

  6. Minsky BD, Cohen A, Enker W,et al. Pre-operative 5-FU, low dose leucovorin, and radiation therapy for locally advanced/unresectable rectal cancer. Int J Radiat Oncol Biol Phys (in press).

  7. American Joint Committee on Cancer. Manual for staging of cancer. Philadelphia: JB Lippincott, 1987.

    Google Scholar 

  8. Minsky BD. Pelvic radiation therapy in rectal cancer: technical considerations. Semin Radiat Oncol 1993;3:42–7.

    PubMed  Google Scholar 

  9. Harrison LB, Enker WE, Anderson LL. High dose intraoperative radiation therapy for colorectal cancer. Oncology 1995;9:679–83.

    PubMed  Google Scholar 

  10. Kaplan EL, Meier P. Nonparametric estimation for incomplete observation. J Am Stat Assoc 1958;53:457–81.

    Google Scholar 

  11. Meade PG, Blatchford GJ, Thorson AG, Christensen MA, Ternent CA. Preoperative chemoradiation downstages locally advanced ultrasound-staged rectal cancer. Am J Surg 1995;170:609–13.

    PubMed  Google Scholar 

  12. Picciocchi A, Coco C, Magistrelli P,et al. Concomitant preoperative radiochemotherapy in operable locally advanced rectal cancer. Dis Colon Rectum 1994;37(Suppl):S69–72.

    PubMed  Google Scholar 

  13. Weinstein GD, Rich TA, Shumate CR,et al. Preoperative infusional chemoradiation and surgery with or without an electron beam intraoperative boost for advanced primary rectal cancer. Int J Radiat Oncol Biol Phys 1995;32:197–204.

    PubMed  Google Scholar 

  14. Bosset JF, Pavy JJ, Hamers HP,et al. Determination of the optimal dose of 5-fluorouracil when combined with low dose d,l-leucovorin and irradiation in rectal cancer: results of three consecutive phase II studies. Eur J Cancer 1993;29:476–86.

    Google Scholar 

  15. Landry JC, Koretz MJ, Wood WC,et al. Preoperative irradiation and fluorouracil chemotherapy for locally advanced rectosigmoid carcinoma: phase I-II study. Radiology 1993;188:423–6.

    PubMed  Google Scholar 

  16. Haghbin M, Sischy B, Hinson J. Combined modality therapy in poor prognostic rectal adenocarcinoma. Radiother Oncol 1988;13:75–81.

    PubMed  Google Scholar 

  17. Chen ET, Mohiuddin M, Brodovsky H, Fishbein G, Marks J. Downstaging of advanced rectal cancer following combined preoperative chemotherapy and high dose radiation. Int J Radiat Oncol Biol Phys 1994;30:169–75.

    PubMed  Google Scholar 

  18. Cooper SG, Bonaventura A, Ackland SP,et al. Pelvic radiotherapy with concurrent 5-fluorouracil modulated by leucovorin for rectal cancer: a phase II study. Clin Oncol 1993;5:169–73.

    Google Scholar 

  19. Chan A, Wong A, Langevin J, Khoo R. Preoperative concurrent 5-fluorouracil infusion, mitomycin-c and pelvic radiation therapy in tethered and fixed rectal carcinoma. Int J Radiat Oncol Biol Phys 1993;25:791–9.

    PubMed  Google Scholar 

  20. Frykholm G, Glimelius B, Pahlman L. Preoperative irradiation with and without chemotherapy (MFL) in the treatment of primary non-resectable adenocarcinoma of the rectum: results from two consecutive studies. Eur J Clin Oncol 1989;11:1535–4l.

    Google Scholar 

  21. Chari RS, Tyler DS, Anscher MS,et al. Preoperative radiation and chemotherapy in the treatment of adenocarcinoma of the rectum. Ann Surg 1995;221:778–87.

    PubMed  Google Scholar 

  22. Rich TA, Skibber JM, Ajani JA, et al. Preoperative infusional chemoradiation therapy for stage T3 rectal cancer. Int J Radiat Oncol Biol Phys 1995;32:1025–9.

    PubMed  Google Scholar 

  23. Stryker SJ, Kiel KD, Rademaker A, Shaw JM, Ujiki GT, Poticha SM. Preoperative “chemoradiation” for stages II and II rectal carcinoma. Arch Surg 1996;131:514–9.

    PubMed  Google Scholar 

  24. Willett CG, Warland G, Hagan MP,et al. Tumor proliferation in rectal cancer following preoperative irradiation. J Clin Oncol 1995;13:1417–24.

    PubMed  Google Scholar 

  25. Minsky BD, Cohen AM, Enker WE, Paty P. Sphincter preservation with preoperative radiation therapy and coloanal anastomosis. Int J Radiat Oncol Biol Phys 1995;31:553–9.

    PubMed  Google Scholar 

  26. Rouanet P, Fabre JM, Dubois JB,et al. Conservative surgery for low rectal carcinoma after high-dose radiation. Functional and oncologic results. Ann Surg 1995;221:67–73.

    PubMed  Google Scholar 

  27. Mohiuddin M, Ahmad N, Marks G. A selective approach to adjunctive therapy for cancer of the rectum. Int J Radiat Oncol Biol Phys 1994;27:765–72.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

About this article

Cite this article

Grann, A., Minsky, B.D., Cohen, A.M. et al. Preliminary results of preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for clinically resectable T3 rectal cancer. Dis Colon Rectum 40, 515–522 (1997). https://doi.org/10.1007/BF02055370

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02055370

Key words

Navigation